Abstract
Purpose: :
Recipients of orthotopic corneal allografts experiencing prolonged graft survival develop regulatory T cells that suppress immune responses to donor alloantigens. CD4+CD25+ regulatory T cells (Treg) play an important role in maintaining immune privilege in the eye, in part, by producing IL-10. Recent studies in liver, skin and cardiac transplantation demonstrate that CD4+CD25+ Treg cells play an important role in the long-term allograft survival. We hypothesize that CD4+CD25+ Treg contribute to the immune privilege exhibited by corneal allografts.
Methods: :
Corneal allografts were performed by surgically removing 2mm cornea buttons from donor mice and were sewn into place on the recipient mice with 11-0 running suture. Depletion of CD4+CD25+ Treg cells was performed by administering anti-CD25 antibody weekly. IL-10 was depleted by administering weekly doses of anti-IL-10 antibody. Balb/c mice were adoptively transferred with either CD4+CD25+ Treg cells or CD4+CD25- T cells isolated by MACS bead separation from naïve Balb/c mice prior to receiving B6 corneal allografts.
Results: :
Splenectomy of recipient CB6F1 mice exacerbated rejection of NZB donor corneal allografts compared to normal controls. Depletion of CD4+CD25+ Treg cells with anti-CD25 antibody in CB6F1 or Balb/c recipients significantly increased the incidence and tempo of NZB or B6 donor corneal allograft rejection compared to the isotype control group. IL-10 depleted recipient mice exhibited accelerated and universal corneal allograft graft rejection. Adoptive transfer of CD4+CD25+ Treg cells into Balb/c recipient mice decreased the incidence of B6 corneal allograft rejection compared to recipient mice adoptively transferred with CD4+CD25- T cells (20% rejection vs. 50% rejection).
Conclusions: :
Immune privilege experienced by corneal allografts is due, in part, to the generation of CD4+CD25+ regulatory T cells in the eye and implies that IL-10 production by Treg cells and NKT cells is critical for corneal allograft survival. Augmenting CD4+CD25+ Treg cells in corneal allograft recipients may be a feasible strategy to blunt immune rejection of corneal allografts and improve long-term graft survival.
Keywords: immune tolerance/privilege • cornea: basic science • immunomodulation/immunoregulation